Agenus

Filed a patent for "methods of treating melanoma using an anti-ctla4 antibody" on Tue, March 28, 2023

Filed a patent for "t cell receptors that bind to mixed lineage leukemia (mll)-specific phosphopeptides and methods of use thereof" on Thu, September 12, 2024

Filed a patent for "anti-ilt4 antibodies and antigen-binding fragments" on Thu, July 11, 2024

Filed a patent for "anti-cd96 antibodies and methods of use thereof" on Thu, June 27, 2024

Filed a patent for "anti-gitr antibodies and methods of use thereof" on Thu, February 9, 2023

Filed a patent for "identification of mhc class i phospho-peptide antigens from breast cancer utilizing shla technology and complementary enrichment strategies" on Thu, February 23, 2023

Filed a patent for "anti-tigit and anti-cd96 antibodies" on Thu, January 19, 2023

Filed a patent for "antibodies and methods of use thereof" on Thu, December 14, 2023

Filed a patent for "antibodies and methods of use thereof" on Thu, December 21, 2023

Filed a patent for "methods of administering anti-ox40 antibodies" on Thu, April 6, 2023

Filed a patent for "methods of administering anti-ox40 antibodies" on Thu, June 1, 2023

Filed a patent for "fibroblast activation protein (fap) car-invariant natural killer t cells and uses thereof" on Tue, October 4, 2022

Filed a patent for "methods of treating colorectal cancer using an anti-ctla-4 antibody" on Mon, October 31, 2022

Filed a patent for "b-cell maturation antigen (bcma) chimeric antigen receptor invariant natural killer t cells and uses thereof" on Fri, November 4, 2022

Filed a patent for "invariant natural killer t cells for treating acute respiratory distress syndrome (ards)" on Sun, November 6, 2022

Filed a patent for "anti-ctla-4 antibodies and methods of use thereof" on Thu, October 19, 2023

Filed a patent for "t cell receptors that bind to ny-eso-1 and methods of use thereof" on Thu, March 28, 2024

Filed a patent for "methods of treating colorectal cancer using an anti-ctla-4 antibody" on Thu, April 20, 2023

Filed a patent for "invariant natural killer t cells for treating acute respiratory distress syndrome (ards)" on Fri, May 19, 2023

Filed a patent for "anti-tigit and anti-cd96 antibodies" on Thu, May 2, 2024

Filed a patent for "anti-tigit antibodies and methods of use thereof" on Thu, May 2, 2024

Filed a patent for "anti-pd-1 antibodies and methods of use thereof" on Thu, November 24, 2022